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Wear Resistant and Biocompatible Coatings for Medical Devices
and Method of Fabrication
[0001] This disclosure relates generally to coatings for articles such as medical
devices, especially artificial implants and other devices fabricated for use inside the
body, and the methods of preparing the coatings. More specifically, this disclosure
relates to durable grafted coatings, which are biocompatible, resistant to wear, and
can prevent the release into the body of any bulk material from which the articles

are made.

[0002] The statements in this section merely provide background information
related to the present disclosure and may not constitute prior art. Medical devices
and biomedical implants may be fabricated from metal, ceramic, plastics, or a

combination. Medical devices used inside the body, such as artificial implants, can
release particles into the body due to wear or erosion, resulting in the release of
immunogenic substances.

The release of such particles may cause infection,

inflammation, destruction of bone and muscle, or other negative effects on the
body.
artificial

For example, after total hip replacement surgery using a metal-on-plastic
implant,

periprosthetic

osteolysis

(bone loss in the vicinity

of the

replacement joint) constitutes one of the most recurring complications leading to
reduced lifetimes for these implants.

Other materials used in artificial implants,

including ceramic or metal-on-metal parts, have their own inherent disadvantages.
The problem with metal-on-metal parts is the release of small metal particles into
the body which can cause inflammation and also infection if passed into the
bloodstream.

Ceramic implants possess higher resistance to wear than metal

implants; however, the brittle nature of ceramics increases the risk of fracture or
breakage.

Such problems with artificial implants can cause premature failure,

requiring a replacement revision surgery, which is not always as successful as the
original surgery and presents additional high risks for the elderly.

[0003] The biological fluids that coat the surface of the hip joint do not sufficiently
wet the surface, leading to increased friction and ultimately the release of wear
particles. This is due to the hydrophobic nature of HMWPE in aqueous biological
fluids.

Wear particles generated cause an immune response and result in

macrophages that release proteolytic enzymes that will not only destroy the wear

particles but also result in the erosion of bone in the vicinity of the prosthesis.

Current research has been dedicated to grafting surface functional groups and
hydrophilic, biocompatible polymers to the HMWPE surface to create a wettable
surface, thereby reducing the abrasion and formation of wear particles.

The

grafted polymers must be not only biocompatible, but must also be uniformly
deposited onto the surface of the implant and be strong enough to withstand
friction-resulting movement expected during usage.
[0004] Surface attachment of polymers has been accomplished by various

methods including chemical or radiation based free-radical or ionic grafting,
photochemical grafting, plasma induced grafting and enzymatic grafting. Some of
the photochemical and radiation based techniques are time intensive, and often the

attachment of the polymer to the substrate is difficult to achieve uniformly. Plasma
treatment, on the other hand, utilizes high-energy, ionized species (or excited state
species) to create active sites on the surface of the substrate necessary for grafting
of chemicals. Exposure of the liquid polymer/monomer solution to the active sites
on the surface results in the formation of chemical bonds.

[0005]

Plasma assisted polymerization has been established previously.

For

example, a multi-step process in U.S. Patent No. 8,178,168 uses plasma treatment
of a free radical initiated polymerisable monomer solution with soft ionization
plasma to prevent defragmentation of the polymer before depositing to a substrate,
leaving the coated substrate with the same features as that of the bulk polymer.
U.S. Publication No. 201 0/00350741 presents a method of graft polymerization with

atmospheric pressure plasma to covalently bond polymers to silicone substrates
using a multi-step process of surface activation and exposure to a humidity

chamber before grafting.

Atmospheric pressure has been known to offer an

advantage over vacuum plasma due to its ease of in-line processing, lower
maintenance costs, and faster processing times.
[0006] Additionally, plasma methods have been employed to improve surfaces for

biomedical applications.

U.S. Patent No. 7,608,839 shows a method of using

atmospheric pressure plasma for applications such as detachment of cells or skin
treatments.

U.S. Patent No. 8,426,199

includes a method for improving

biocompatibility of surfaces using various plasma treatments including microwave
or atmospheric pressure. U.S. Publication No. 201 0/0203339 presents a method of

depositing carbon based films to decrease friction and improve wear properties for
steel substrates.

[0007] Attaching various polymers or other chemical agents to substrates using

plasma methods and/or wet chemical techniques has been shown to be successful
for various applications.

The method described

U.S. Publication

in

No.

2010/0255053 can be used to produce porous scaffolds for medical devices with
bioactive compounds applied using plasma or other spraying techniques.

In U.S.

Publication No. 201 1/0008407, both osseointegration and antimicrobial agents
were integrated to various substrates to improve bone growth and eliminate
infection.
containing

U.S. Publication No. 201 1/0189493 presents a method to crosslink S i

molecules

biocompatibility.

with

plasma

polymerization

in

order

to

improve

Plasma assisted spraying techniques shown in U.S. Publication

No. 2012/01 71354 result in attachment of materials including biomolecules and

living cells to substrates, such as metals to improve bone fixation for medical

implants.
[0008] The examples in the related art fall short in accomplishing wear resistance
as well as biocompatibility that is necessary for articles fabricated for use in a

human or animal body.

BRIEF SUMMARY OF THE INVENTION
[0009] The present disclosure provides coatings for articles that are fabricated for
use inside a human or other animal body, such as biomedical implants and other

medical devices. The articles may be made from any metallic, ceramic, or plastic
material, including any combination thereof.

activation of chemical

The method of coating includes

precursors using atmospheric

pressure plasma and

subsequent surface grafting and cross-linking of monomeric and polymeric
molecules to form a solid coating. Optionally, a sub-layer can be applied to the
article to provide additional functionality. Alternatively, the surface of the article or

the surface of the optional sub-layer may pre-treated before application of the

coating.
[0010] The chemical precursors for use in coating the articles may comprise

polymers, monomers, other small molecules, or mixtures thereof.

The chemical

precursors may be dissolved in water or other solvents. According to one aspect of
the present disclosure, the chemical precursors contain a polymer or monomer that

has demonstrated

biocompatibility

and

biological

inertness.

The

chemical

precursors may also include other chemicals that provide alternate functionality to
the coating, such as increased wear resistance, cross-linking, or hydrophilicity, as
well as any other physical or chemical function desired for a specific application.
[001 1]

The chemical precursors are activated by atmospheric pressure plasma,

which partially dissociates the chemical precursors, grafts the chemical precursors
to the surface of the article, and cross-links the chemical precursors to form the
coating. According to one aspect of the present disclosure, the chemical precursor
is delivered to the surface of the article simultaneously as the atmospheric pressure

plasma is directed towards the surface of the article. The chemical precursor may
be delivered by any form of an atomization or a spray process that uses nitrogen,

air, noble gas, or a combination of said gases capable of transporting the chemical
precursors.

In yet

another aspect of the present disclosure,

the chemical

precursors are vaporized before directed to the surface of the article. The chemical
precursors can also be applied to the entire surface of the article by dip coating,
flow coating, spray coating, or spin coating prior to exposure to plasma for
activation and cross-linking.
[0012]

At the same time as delivery of the precursors or subsequent thereto,

atmospheric pressure plasma is directed towards the surface of the article, which
activates the chemical precursor by partial molecular dissociation, followed by
surface grafting and/or cross-linking of the activated precursor molecules to form a
solid coating. The atmospheric pressure plasma may be generated by any feasible
method of generating plasma under atmospheric conditions, such as electrical
ignition using direct current (DC), alternating current (AC), or pulsed current, among
others.

The type of plasma source selected can include, but is not limited to,

Dielectric Barrier Discharge (DBD), microwave plasma systems, hollow cathode
systems, various plasma jets, and plasma arrays.
[0013]

According to another aspect of the present disclosure, a sub-layer is

applied to the article to provide additional functionality to the article. A n example of
such a sub-layer is a ceramic or tribological layer to provide additional wear and
abrasion resistance and/or to increase adhesion of the article to coating. This s ub
layer may applied by any means known to one skilled in the art, including physical

vapor deposition, chemical vapor deposition, or plasma enhanced chemical vapor
deposition.
[0014] When desirable, the surface of the article may be chemically modified with

a pre-treatment before application of the coating. The method of pretreatment may
be selected from any means known to one skilled in the art, including, but not

limited to, plasma and corona treatment, chemical etching, priming with other

chemicals, applying an adhesive film, and/or physical abrasion. Alternatively, the
surface pre-treatment is performed using atmospheric pressure plasma exposure.
[0015]

Further areas of applicability will become apparent from the description

provided herein.

It should be understood

that the description and specific

examples are intended for purposes of illustration only and are not intended to limit
the scope of the present disclosure.

BRIEF DESCRIPTION OF THE DRAWINGS
[0016] The drawings described herein are for illustration purposes only and are

not intended to limit the scope of the present disclosure in any way.
[0017]

Figure 1 is a schematic representation of a process or method used to

form an article having a protective coating according to the teachings of the present
disclosure.
[0018]

Figure 2 is a schematic representation of a process or method used to

graft biocompatible polymers to the substrate in one aspect of the invention.
[0019]

Figures 3 and 4 contain schematic representations of various apparatus

configurations for coating a substrate according to the teachings of the present
disclosure, in which the symbol 'A' denotes a plasma generator, the symbol 'B'
denotes a chemical precursor, and 'C denotes the substrate to be coated;
[0020]

showing

Figures 5A-5E are Fourier Transform Infrared Spectroscopy (FTIR) spectra
measurements

polyethylene
hydroxyethyl

(HMWPE)

obtained

from

untreated

and plasma coatings

methacrylate)

(PHEMA),

molecular

weight

using the precursors

poly(2-

high

hydroxyethylmethacrylate

(HEMA),

polyethylinemine (PEI), and polyethylene glycol (PEG) ;
[0021]

Figures 6A-6D are FTIR spectra that show a comparison of the grafted

surfaces corresponding to those plots shown in Figures 5B-5E with the bulk form of
each polymer;

[0022]

Figure 7 is a graphical representation of contact angle measurements from

untreated HMWPE and grafted surfaces, according to the teachings of the present
disclosure;
[0023]

Figure 8 is a table that shows adhesion testing results for the PHEMA and

PEI grafted surfaces;

[0024]

Figure 9 is a table that compares thickness of grafted coatings for HEMA

grafted to HMWPE substrates;
[0025]

Figure 10 is a graphical representation of the results of wear testing for

PHEMA grafted surfaces as compared to the untreated HMWPE; and
[0026]

Figure 11 is another table that shows adhesion testing results for the

PHEMA and PEI grafted surfaces.

DETAILED DESCRIPTION
[0027] The following description is merely exemplary in nature and is in no way

intended to limit the present disclosure or its application or uses.

It should be

understood that throughout the description, corresponding reference numerals
indicate like or corresponding parts and features.
[0028] The present disclosure generally relates to a coating for use in articles,
such as biomedical implants or medical devices, which makes contact with tissues
and fluids inside a living body, especially those that may release particles into the

body due to motion and/or erosion.

The present disclosure also relates to a

method of applying said coating to the surface of the articles in preparation of these

articles being implanted or used within the body.
[0029] According to one aspect of the present disclosure, the composition of the

coating is derived from polymeric and monomeric chemical precursors that are
biocompatible, biologically inert, and/or generally inhibit immune response inside
the body.

The method of activation of the chemical precursors includes

atmospheric pressure plasma, which partially dissociates the chemical precursors
and subsequently grafts the chemical precursors to the surface of the article and

cross-links the activated chemical precursors to form a solid, durable coating.
Alternatively, a sub-layer may be applied to the surface of the article prior to
application of the coating in order to provide additional functionality, such as
increased hardness and resistance to wear. Alternatively, the surface of the article
may be chemically modified with a pre-treatment before coating.

[0030]

The article or substrate upon whose surface the coating is applied may

include any device that is fabricated for use as a biomedical implant, medical
device, or other object that is inserted into or contacts the tissue, organs, or fluids
present inside the body of a human or animal.

The choice of the material of

construction for such an article or substrate may include any material selected as
one from the group of metal, ceramic, plastic, and combination thereof.

[0031]

The coating is composed of chemical precursors that are biocompatible

and/or biologically inert.

The chemical precursors may consist of polymeric

materials, monomeric materials, or a combination thereof. The polymeric materials
may include, but not be limited to, one or more of polymethacrylates, polyacrylates,
polyurethanes,

polyethylene,

polyanhydrides,

polyesters,

polyglycolic

acid,

polylactic acids, polycaprolactone, and polyketones.

Alternatively, the polymeric

materials may include polyhydroxyethylmethacrylate

(pHEMA), polyethylenimine

(PEI), polyvinyl alcohol, polyethylene

glycol (PEG), or polyvinyl pyrolidone.

Alternatively, the polymeric materials may include any polymer approved by the
Federal Drug Administration (FDA) for use in the human body.
[0032]

Monomers or small molecules may be used individually as coating

precursors or they may also be used in conjunction with polymeric materials in
order to provide increased cross-link density and/or add other functional groups
and properties to the coatings.

Alternatively, other molecules, including but not

limited to oligomers, may be added to the coating precursors.

These other

molecules are independently selected to provide additional functionality to the
coating based on a desired function or property. The coating precursor or mixture
of precursors is selected to provide the level of wear resistance, cross-link density,
biocompatibility, and other properties of the coating based on the substrate material
and final intended application of the article.

[0033]

According to another aspect of the present disclosure, the coating

precursor may be initially in a liquid phase or a vapor phase prior to being applied
to the surface of the article.

If the precursor exists in a solid phase under

atmospheric pressure and temperature, the solid may be dissolved in a solution of
water, monomer, other solvent, or a combination thereof.
[0034]

The coating precursor is delivered to the surface of the article by any

means of flow, dip, spray, atomization, or vapor delivery known to one skilled in the

art. In one example of such an application process, a flow of a carrier gas can be

directed to the surface of the article. The chemical precursor is allowed to enter or
be injected or drawn into this gas stream.

In this specific case, the carrier gas for

the chemical precursor delivery may be any gas that does not form a solid coating,
such as nitrogen, oxygen, noble gases, carbon dioxide, or any combination thereof.
The flow rate of the chemical precursors, flow rate of the carrier gas, and flow exit
location may be tailored based on the substrate material and final application of the
article. Simultaneous to chemical precursor delivery, plasma arising from a plasma
generator can be directed towards the surface of article. The surface of the article
is thus exposed to atmospheric pressure plasma for the creation of reactive sites,

while the precursor is activated by partial dissociation, followed by surface grafting
and cross-linking. In another method, a liquid precursor can be injected directly into

the plasma exiting the plasma generator.

[0035]

Referring to Figure 1, the method 100 may be generally described as

comprising the steps of providing 105 an article having an external surface;
selecting 110 chemical precursors; using a means to direct 115 one or more
chemical precursors towards or to apply 120 such chemical precursors to the
external

surface;

activating

the chemical

precursors

125 by exposing

said

precursors to atmospheric pressure plasma; and grafting and/or cross-linking the
chemical precursors 130 to form a solid coating adjacent to the external surface of
the article. Optionally, the method 100 may further comprise the step of applying a
sub-layer 135 to the external surface of the article or pre-treating 140 the external
surface prior to the application of the solid coating.

In this case, the sub-layer or

the pretreatment is capable of enhancing adhesion of the solid coating to the
article, providing additional wear or abrasion resistance, or increasing hardness of
the coating.

[0036] Atmospheric pressure plasma is used to activate the surface of the article
to create attractive or radical sites for bonding to the coating. Simultaneously, the

plasma reacts with the chemical precursors to create a reactive site on the
molecules and graft them to the surface of the article as well as cross-link the
precursor molecules to form a coating, as shown in Figure 2 . The gas for the
plasma may be any gas that can be ionized by a plasma generator that does not
form a solid coating, such as nitrogen, oxygen, any noble gases, carbon dioxide, or

any combination. The plasma may be generated by any plasma generator that can
create a low temperature

homogeneous

plasma discharge in atmospheric

conditions that is spatially separated from the plasma generation zone and electric
field. The spatial separation of the chemical precursors from the plasma generation

results in preservation of some features of the original molecule. This is particularly

beneficial for materials with biocompatible or bioactive properties. The plasma can
be powered using direct current (DC), pulsed-DC, radio frequency (RF), or

microwave (MW) technology.

One commercial example of such a plasma

generator is the Openair® technology (Plasmatreat US LP, Elgin, Illinois).

The

plasma conditions, which are controllable and variable during the coating process,
include the type of gas, energy parameters, the flow rate of gas, the distance from
the substrate, and the rate of scanning. The optimum plasma conditions may differ

for each combination of substrate, chemical precursor, and final application of the
article.

In general, the set of plasma conditions are tailored to meet the desired

wear resistance, adhesion, durability, biocompatibility, hydrophilicity, and other
desired properties of the applied coating.
[0037]

According to another aspect of the present disclosure, a sub-layer may be

applied to the surface of the article to provide additional functionality to the article.

For example, a ceramic or tribological sub-layer may be applied to provide
additional durability, resistance against wear, and/or physical barrier. The method
of application of the sub-layer may include physical vapor deposition (PVD),
chemical vapor deposition (CVD), or plasma enhanced chemical vapor deposition
(PECVD). Alternatively, the method of application is atmospheric pressure plasma

deposition.
[0038]

According to yet another aspect of the present disclosure, the surface of

the article, the surface of the sub-layer, or both surfaces are chemically modified
using a pre-treatment process to increase chemical bonding of the surface to the

coating.

This surface pre-treatment method involve any process known to one

skilled in the art including, but not limited to, plasma and/or corona treatment,

chemical etching, priming with other chemicals, application of adhesive coatings,
physical abrasion, or atmospheric pressure plasma exposure.

Alternatively, the

surface pre-treatment method involves exposing the surface of the article and/or
sub-layer to atmospheric pressure plasma. The gas used for plasma pre-treatment

may include any gas that does not form a solid coating from the plasma phase,
including but not limited to, nitrogen, oxygen, water vapor, carbon dioxide, noble
gas, or any combination of gases. The "desired" level of pre-treatment is that which

will remove contaminants from the surface and create attractive or radical sites on
the surface to increase bonding of the coating to the surface without damage to the
article.

[0039] The following specific embodiments are given to illustrate the design of a

wear resistant and biocompatible coating and a method of applying such a coating
according to the teachings of the present disclosure and should not be construed to
limit the scope of the disclosure.

Those skilled-in-the-art, in light of the present

disclosure, will appreciate that many changes can be made in the specific
embodiments which are disclosed herein and still obtain alike or similar result
without departing from or exceeding the spirit or scope of the disclosure.

One

skilled in the art will further understand that any properties reported herein

represent properties that are routinely measured and can be obtained by multiple
different methods. The methods described herein represent one such method and
other methods may be utilized without exceeding the scope of the present
disclosure.
[0040]

Example 1

[0041]

Polymer coatings made with biocompatible materials have been grafted

onto high density polyethylene (HDPE) via atmospheric pressure plasma reacting

with the chemical precursor. Example 1 involves poly(2-hydroxyethyl methacrylate)

(pHEMA) and its monomer (HEMA), in which dilute, aqueous precursor solutions
were applied to HMWPE substrates and atmospheric pressure plasma was used to
graft the pHEMA and chemical reaction products of pHEMA, or alternatively used to
polymerize the monomer (HEMA), on the substrate surface.

General process

description is shown in Figure 2 .
[0042]

For some cases, the HMWPE substrate was first pre-treated by exposure

to the plasma using air as the ionization gas. The purpose of the pretreatment was
to activate the surface of the HDPE to allow for the pHEMA coating to bond to the

active sites newly created on the surface. After pretreatment, the substrate was
coated using the atmospheric pressure plasma coating process.

The process

involved spray application of the liquid precursor (the dilute pHEMA solutions or

HEMA monomer) into the plasma stream using a carrier gas, as shown in Figure 3 ,
as well as spray application of the liquid precursor prior to plasma exposure, as

shown in Figure 4 . Compressed dry air was used as the ionization gas for the
plasma.
[0043] The process conditions were varied in order to understand their effects on

the coating outcomes.

The following lists the variables and ranges used for

creating the coatings:
•

Plasma power

•

Scanning speed, which determines thickness (5 - 20 m/min)

•

Distance from plasma to substrate

•

Spray precursor delivery pressure, which determines flow rate (20 - 30 psig)

•

Pre-treatment with atmospheric plasma (applied / not applied)

•

Number of scans, where each scan is considered 1 coating layer

( 1 .0

- 1.4 kW)

( 1 .5

- 2.5 cm)

(1

- 9)

[0044] The coatings were analyzed using FTIR to evaluate chemical surface

changes, contact angle to assess compatibility with aqueous fluid inside the body,
and adhesion to determine the surface grafting strength and uniformity.

Figure 5

(a, b, and c) shows a sample FTIR measurement for pHEMA and HEMA grafted

surfaces, as compared to untreated HMWPE.

The FTIR results clearly show a

significant chemical change on the surface of the HMWPE. Additionally, Figure 6
shows a comparison FTIR of pure pHEMA solution and HEMA monomer as
compared to a pHEMA and HEMA grafted HMWPE surface.
[0045] Contact angle data using deionized (Dl) water droplets were obtained for

the samples plasma coated with pHEMA precursor solution and HEMA monomer.

The water contact angle provides an indication of the hydrophilicity, as well as
compatibility of the coatings with the internal aqueous body fluids. The effects of all
of the factors were analyzed, with only the precursor delivery method as a
significant factor. Figure 7 shows the mean contact angle values of the untreated
HMWPE and the plasma coated HMWPE samples.

The results showed a

significant decrease in contact angle for the samples with pHEMA plasma coating,
indicating a significantly hydrophilic and water compatible surface.
[0046] The adhesion testing was carried out using a tape test, ASTM D3359. A
Crosshatch pattern is marked on the sample using a blade tool, and a piece of tape

is secured over the Crosshatch and removed rapidly; the resulting Crosshatch area
is inspected and rated as either a pass or fail, along with the percentage of cross-

hatch squares that failed.

The samples pre-treated with plasma all passed

adhesion, while those without plasma pre-treatment failed adhesion. Therefore, it
can be said that the pre-treatment was necessary to promote bonding between the

pHEMA precursor and the HMWPE substrate.

Figure 8 shows the results of the

adhesion studies for pHEMA grafted surfaces.
[0047] Grafted coatings of HEMA to HMWPE were analyzed for thickness and

these results are shown in Figure 9 . Thicknesses were approximately 2 microns in
some cases, significantly higher than previous results with other grafting methods,
not including atmospheric pressure plasma.
[0048] A stainless steel pin driven by an actuator made by Thomson Saginaw Ball

Screw Company, LLC, Saginaw, Ml, was used as the primary device to conduct the
wear experiments, to create a similar testing to a pin-on-disk wear test.

The

movement of the pin was random across the surface of the plaque. The mass of
the semispherical pin (diameter 0.008m) was 2.1 1kg, resulting in a total contact

pressure affecting the specimen equal to 4.12x10 N/m 2 . Water was used to
completely cover the test plaques during the wear testing.

Wear tests were run

over the course of one week for each sample, with average run times of 60 hours.
Similar techniques have been used in literature. Results of preliminary wear testing
are shown in Figure 10 for both pHEMA grafted surfaces as compared to untreated

HMWPE.
[0049] Cell proliferation studies using FKBP52 Knockout Mouse Embryonic

Fibroblast (52KO MEF) cells were performed to analyze the biocompatibility of the
PHEMA grafted surfaces. Preliminary findings after 6 days indicate no adverse
effects on cell viability due to the plasma treatment.
[0050]

Example 2

[0051]

Example 2 involves aqueous solutions of polyethylinemine

(PEI) as

chemical pre-cursor applied to HDPE substrates and atmospheric pressure plasma
was used to graft the PEI and chemical reaction products of PEI to the substrate
and cure the coatings. Refer to Figures 2-4 for methods of grafting. The following

process conditions were varied for analysis of their effects:
•

Concentration of precursor solution (4 - 16 wt% PEI in D l water)

•

Plasma power (0.9 - 1.4 kW)

•

Scanning speed, which determines thickness (10 - 20 m/min)

•

Pre-treatment with atmospheric plasma (applied / not applied)

•

Number of scans, where each scan is considered 1 coating layer

(1

- 9)

Figure 5 shows the FTIR results for PEI plasma coating and untreated

[0052]

HDPE. These samples were generated by pre-application of precursor with a spray
gun mounted onto the moving plasma jet spraying the samples before plasma

exposure, as shown in Figure 3 . As seen in this chart, the broad -OH peak is
apparent at 3300cm
chemistry.

1

and the PEI plasma coating significantly modified the surface

Additionally, Figure 6 shows the FTIR comparison for pure PEI as

compared to the PEI grafted HMWPE.
In addition to FTIR, contact angle analysis was performed for PEI samples

[0053]

to assess the compatibility of the surfaces with aqueous solution as in the body.

Contact angle measurements were obtained using D l water and albumin, which
represents a similar make-up as body fluid. The results in Figure 7 show that the
coatings were significantly hydrophilic.
[0054] The adhesion testing was carried out using a tape test, ASTM D3359, as

described in the previous example.

As in the previous example, plasma pre-

treatment was necessary pass the adhesion test and to promote better bonding
between the liquid precursor and the HDPE substrate.

In some cases, coatings

failed adhesion due to the inadequate plasma power to dissociate the bonds for
proper grafting. Figure 11 shows the results of the PEI grafted surfaces adhesion
testing.
[0055]

Example 3

[0056] The third example included aqueous solutions of 25 wt% polyethylene
glycol (PEG) as a chemical pre-cursor that was applied to HDPE substrates.

Atmospheric pressure plasma was used to graft the PEG and chemical reaction
products of PEG to the substrate and cure the coatings. The following process
conditions were varied for analysis of their effects:
•

Plasma power (0.9 - 1.3 kW)

•

Number of scans, where each scan is considered 1 coating layer

•

Pre-treatment with atmospheric plasma (applied / not applied)

(1,

3)

[0057]

Figures 5 and 6 show the FTIR results for PEG plasma coating and

untreated HMWPE.

The PEG plasma coated samples were generated by pre-

application of precursor with a spray gun mounted onto the moving plasma jet
spraying the samples before plasma exposure, as shown in Figure 3 . As seen in
this chart, PEG plasma coating significantly modified the surface chemistry.
[0058] Contact angle analysis was performed for PEG samples to assess the

compatibility of the surfaces with aqueous solution as in the body. Contact angle
measurements were obtained using D l water. The results in Figure 7 show that the
coatings were significantly hydrophilic, indicating compatibility with aqueous
solutions, such as in the body.
[0059]

Example 4

[0060] The fourth example includes the addition of a highly abrasion resistant

coating as sublayers underneath the plasma coatings made with polyvinyl alcohol)

(PVA) in aqueous solution as a precursor.

The abrasion resistant layer was

created by depositing organosilicon coating via atmospheric pressure plasma

deposition. Dilute, aqueous precursor solutions (< 1.5 wt.% of PVA) were applied
to HDPE substrates that had been coated with the organosilicon layer, and

atmospheric pressure plasma was used to graft the precursor and the chemical
products to the substrate and cure the coatings.
[0061] The foregoing description of various forms of the invention has been

presented for purposes of illustration and description.

It is not intended to be

exhaustive or to limit the invention to the precise forms disclosed.

Numerous

modifications or variations are possible in light of the above teachings. The forms
discussed were chosen and described to provide the best illustration of the
principles of the invention and its practical application to thereby enable one of
ordinary skill in the art to utilize the invention in various forms and with various
modifications as are suited to the particular use contemplated.

All such

modifications and variations are within the scope of the invention as determined by
the appended claims when interpreted in accordance with the breadth to which they
are fairly, legally, and equitably entitled.

CLAIMS
What is claimed is

1.

A method of forming a biocompatible or biologically inert article for

use in an application in which the article will make contact with at least one tissue,

organ, or fluid within a human or animal body; the method comprising the steps of:

providing an article having an external surface;
selecting chemical precursors;
using a means to direct one or more chemical precursors towards or
to apply such chemical precursors to the external surface;

activating the chemical precursors by exposing said precursors to
atmospheric pressure plasma; and
grafting and/or cross-linking the chemical precursors to form a solid
coating adjacent to the external surface of the article.

2.

The method according to Claim 1, wherein the method further

comprises the step of applying a sub-layer to the external surface of the article or
pre-treating the external surface prior to the application of the solid coating; the
sub-layer or the pretreatment capable of enhancing adhesion of the solid coating to
the article, providing additional wear or abrasion resistance, or increasing hardness

of the coating.

3.

The method according to Claims 1 or 2 , wherein the article is a

medical device or a biomedical implant having a body constructed from one

selected from the group of a metal, a ceramic, a plastic, or a combination thereof.

4.

The method according to Claims 1-3, wherein the chemical

precursors are selected as one from the group of polymers, monomers, other small
molecules, or mixtures thereof, based upon their ability to exhibit biocompatibility or
biological inertness.

5.

The method according to Claims 1-4, wherein the means of directing

the chemical precursors towards or applying the chemical precursors to the

external surface is one selected as one from the group of dip coating, flow coating,
spin coating, spray or atomization coating, and combination thereof.

6.

The method according to Claim 2 , wherein the pretreatment of the

external surface is accomplished using one selected from the group of plasma or
corona treatment, chemical etching, chemical priming, physical abrasion, or
applying an adhesive film.

7.

The method according to Claims 1-6, wherein the chemical

precursors are selected as one from the group of polymethacrylates, polyacrylates,
polyurethanes, polyethylene, polyanhydrides, polyesters, polyglycolic acid,
polylactic acids, polycaprolactone, and polyketones.

8.

The method according to Claims 1-6, wherein the chemical

precursors are selected as one from the group of polyhydroxyethylmethacrylate
(PHEMA), polyethylenimine (PEI), polyvinyl alcohol, polyethylene glycol, or
polyvinyl pyrolidone.

9.

The method according to Claims 1-8, wherein the chemical

precursors are a polymeric material approved by the Federal Drug Administration
(FDA) for use in the human body.

10.

The method according to Claims 1-9, wherein the chemical

precursors are dissolved in a solution of water, monomer, solvent, or combination
thereof.

11.

The method according to Claims 1- 1 0 , wherein the means of directing

the chemical precursors towards the surface of the article includes injecting or

drawing the precursors into a flow of a carrier gas selected as one from the group
of nitrogen, oxygen, noble gases, carbon dioxide, or a combination thereof.

12.

The method according to Claim 11, wherein the means of directing

the chemical precursors towards the article's surface is controlled using the flow
rate of the chemical precursors, the flow rate of the carrier gas, and the location of

the flow exit approximate the surface.

13.

The method according to Claims 1-12, wherein the activating the

chemical precursors by exposure to atmospheric pressure is accomplished by
creating the atmospheric pressure plasma using a plasma source selected as one
from a Dielectric Barrier Discharge (DBD) system, a microwave plasma system, a
hollow cathode system, a plasma jet, and a plasma array.

14.

The method according to Claims 1-13, wherein the plasma is created

using a plasma generator using direct current, radio frequency, or microwave

technology.

15.

The method according to Claim 2 , wherein the sub-layer is applied

using physical vapor deposition, chemical vapor deposition, atmospheric plasma

deposition, plasma enhanced chemical vapor deposition, or atmospheric pressure
plasma deposition.

16.

A medical device or implant having a biocompatible or biologically

inert external surface; the medical device or implant being prepared according to

the method of any of Claims 1- 1 5 .

17.

A biocompatible or biologically inert coating applied to the surface of

an article according to the method of any of Claims 1-15.
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